Safety and IOP-Lowering Effects of WB007
Conditions: Glaucoma, Primary Open Angle; Ocular Hypertension Interventions: Drug: Study Treatment 1 WB007; Drug: Study Treatment 2 WB007; Drug: Study Treatment 3 WB007; Drug: Timolol 0.5% Sponsor: Whitecap Biosciences, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials